← Evidence map

ReviewPharmaceuticals (Basel, Switzerland)2026

Cefepime and New Cefepime/Beta-Lactamase Inhibitor Combination for the Treatment of Gram-Negative Bacteria: Chemical Structure and Mechanism of Action, Microbiological Target, Clinical Use and PK/PD Characteristics.

Davide Carcione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41754823